Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Molecular Pharmacology|October 6, 2005
EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G proteinHiromichi Fujino, John W ReganEuropean Journal of Pharmacology|March 26, 2003
Prostaglandin F(2alpha) stimulation of cyclooxygenase-2 promoter activity by the FP(B) prostanoid receptorHiromichi Fujino, John W ReganBiochemical and Biophysical Research Communications|April 20, 2004
Prostaglandin F2alpha amplifies tumor necrosis factor-alpha promoter activity by the FPB prostanoid receptorHiromichi Fujino, John W ReganBiochimica Et Biophysica Acta|May 7, 2009
EP(3) prostanoid receptor isoforms utilize distinct mechanisms to regulate ERK 1/2 activationDavelene D Israel, John W ReganThe Journal of Biological Chemistry|February 5, 2003
Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinasesHiromichi Fujino, Wei Xu, John W ReganThe Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
Differential internalization of the prostaglandin f(2alpha) receptor isoforms: role of protein kinase C and clathrinDinesh Srinivasan, Hiromichi Fujino, John W ReganMethods in Enzymology|November 2, 2010
Assessment of constitutive activity in E-type prostanoid receptorsHiromichi Fujino, Toshihiko Murayama, John W ReganThe Journal of Biological Chemistry|October 9, 2002
Cellular conditioning and activation of beta-catenin signaling by the FPB prostanoid receptorHiromichi Fujino, Dinesh Srinivasan, John W ReganMolecular Pharmacology|April 28, 2005
Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2Hiromichi Fujino, Sambhitab Salvi, John W ReganPageof 5